HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Condor Capital Management

Condor Capital Management lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,632 shares of the company’s stock after selling 237 shares during the period. Condor Capital Management’s holdings in HCA Healthcare were worth $4,392,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GSA Capital Partners LLP purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $567,000. Quest Partners LLC increased its position in shares of HCA Healthcare by 384.9% in the 3rd quarter. Quest Partners LLC now owns 3,171 shares of the company’s stock valued at $1,289,000 after purchasing an additional 2,517 shares during the last quarter. Pathstone Holdings LLC increased its position in shares of HCA Healthcare by 23.1% in the 3rd quarter. Pathstone Holdings LLC now owns 27,589 shares of the company’s stock valued at $11,213,000 after purchasing an additional 5,175 shares during the last quarter. Prospera Financial Services Inc increased its position in shares of HCA Healthcare by 204.2% in the 3rd quarter. Prospera Financial Services Inc now owns 2,917 shares of the company’s stock valued at $1,186,000 after purchasing an additional 1,958 shares during the last quarter. Finally, Banque Cantonale Vaudoise grew its position in shares of HCA Healthcare by 25.6% in the 3rd quarter. Banque Cantonale Vaudoise now owns 12,187 shares of the company’s stock valued at $4,953,000 after buying an additional 2,481 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $334.42 on Thursday. The company has a 50-day simple moving average of $320.53 and a 200-day simple moving average of $343.97. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $82.34 billion, a PE ratio of 15.22, a P/E/G ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm posted $5.90 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.86%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Morgan Stanley decreased their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.